Literature DB >> 27928414

Leber Hereditary Optic Neuropathy with Interval of Visual Loss Greater Than 12 Months.

Renata Cristina Ferreira Prado1, Frederico Castelo Moura1.   

Abstract

A 28-year-old man presented with severe left visual loss and normal right visual acuity. The left fundus examination showed temporal pallor and complete absence of the nerve fibre layer (NFL) of papillomacular bundle. Right fundus examination showed focal loss of inferotemporal NFL. Magnetic resonance and serum aquaporin-4 antibody were negative. After 14 months of the initial visual involvement, the patient suffered subacute visual loss in contralateral eye. Genetic study revealed the 11778 point mitochondrial DNA (mtDNA) mutation associated with Leber hereditary optic neuropathy (LHON). Although very rare, interval of involvement of second eye greater than 12 months can occurs in LHON. Detailed optic nerve examination and careful interpretation of optical coherence tomography (OCT) printout support the diagnosis.

Entities:  

Keywords:  Fellow eye involvement; Leber hereditary optic neuropathy; optical coherence tomography

Year:  2016        PMID: 27928414      PMCID: PMC5122931          DOI: 10.1080/01658107.2016.1213860

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  9 in total

1.  The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation.

Authors:  N J Newman; M T Lott; D C Wallace
Journal:  Am J Ophthalmol       Date:  1991-06-15       Impact factor: 5.258

2.  Are we there yet? Is neuro-ophthalmology at the cusp of a paradigm shift? Lessons from leber hereditary optic neuropathy.

Authors:  Alfredo A Sadun
Journal:  J Neuroophthalmol       Date:  2013-06       Impact factor: 3.042

Review 3.  Leber's hereditary optic neuropathy: a multifactorial disease.

Authors:  May-Yung Yen; An-Guor Wang; Yau-Huei Wei
Journal:  Prog Retin Eye Res       Date:  2006-07-07       Impact factor: 21.198

4.  Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations.

Authors:  E K Nikoskelainen; K Huoponen; V Juvonen; T Lamminen; K Nummelin; M L Savontaus
Journal:  Ophthalmology       Date:  1996-03       Impact factor: 12.079

5.  Leber hereditary optic neuropathy: Does heteroplasmy influence the inheritance and expression of the G11778A mitochondrial DNA mutation?

Authors:  P F Chinnery; R M Andrews; D M Turnbull; N N Howell
Journal:  Am J Med Genet       Date:  2001-01-22

6.  The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation.

Authors:  P Riordan-Eva; M D Sanders; G G Govan; M G Sweeney; J Da Costa; A E Harding
Journal:  Brain       Date:  1995-04       Impact factor: 13.501

7.  Atypical Leber Hereditary Optic Neuropathy: 18 Year Interval Between Eyes.

Authors:  Kaitlyn L Ohden; Peter H Tang; Chrystia C Lilley; Michael S Lee
Journal:  J Neuroophthalmol       Date:  2016-09       Impact factor: 3.042

8.  Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy.

Authors:  T Klopstock; G Metz; P Yu-Wai-Man; B Büchner; C Gallenmüller; M Bailie; N Nwali; P G Griffiths; B von Livonius; L Reznicek; J Rouleau; N Coppard; T Meier; P F Chinnery
Journal:  Brain       Date:  2013-02-06       Impact factor: 13.501

Review 9.  The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease.

Authors:  James B Stewart; Patrick F Chinnery
Journal:  Nat Rev Genet       Date:  2015-09       Impact factor: 53.242

  9 in total
  2 in total

1.  Gene Therapy for Leber Hereditary Optic Neuropathy: Low- and Medium-Dose Visual Results.

Authors:  John Guy; William J Feuer; Janet L Davis; Vittorio Porciatti; Phillip J Gonzalez; Rajeshwari D Koilkonda; Huijun Yuan; William W Hauswirth; Byron L Lam
Journal:  Ophthalmology       Date:  2017-06-21       Impact factor: 12.079

2.  The Relationship Between Stage of Leber's Hereditary Optic Neuropathy and Pattern Electroretinogram Latency.

Authors:  Vittorio Porciatti; Diego E Alba; William J Feuer; Janet Davis; John Guy; Byron L Lam
Journal:  Transl Vis Sci Technol       Date:  2022-03-02       Impact factor: 3.283

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.